Review of therapeutic agents for the treatment of COVID-19
| Author | Shadi Ziaie | en |
| Author | Mehran Kouchek | en |
| Author | Mir Mohammad Miri | en |
| Author | Sara Salarian | en |
| Author | Seyed pouzhia Shojaei | en |
| Author | Mehrdad Haghighi | en |
| Author | Mohammad Sistanizad | en |
| Orcid | Mehran Kouchek [0000-0002-2070-9856] | en |
| Orcid | Sara Salarian [0000-0002-4544-8883] | en |
| Orcid | Mehrdad Haghighi [0000-0003-3139-3225] | en |
| Orcid | Mohammad Sistanizad [0000-0002-7836-6411] | en |
| Issued Date | 2020-03-31 | en |
| Abstract | In late December 2019, a cluster of unexplained pneumonia cases has been reported in Wuhan, China, named coronavirus disease 2019 (COVID -19) which has been spreading in 204 countries. In this review, the mains pharmaceutical option quoted previously and especially available for ICU patients are reviewed. | en |
| DOI | https://doi.org/10.22037/jcma.v5i1.29760 | en |
| Keyword | COVID-19 | en |
| Keyword | Pharmacotherapy | en |
| Keyword | Antiviral | en |
| Keyword | Immunomodulators | en |
| Publisher | Brieflands | en |
| Title | Review of therapeutic agents for the treatment of COVID-19 | en |
| Type | Letter | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- jcma-151378.pdf
- Size:
- 502.56 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF